Bellen Chemistry, established in 2010, originally focused on the design and development of hundreds of novel heterocycles. Over a number of years our innovative capabilities and reliable performance were gradually becoming more recognized in the marketplace, and our customers encouraged us to develop CRO/CDMO business with them.

In order to provide better solutions for our customers, the company has undertaken serveral rounds of venture capital financing to support our dynamic growth.

In the past 12 years the company has grown from 6 employees to over 800 employees. In line with our global service commitment, we have also set up Bellen branches in Europe,NA and Asia so as to provide better and faster services to our local customers. Today we provide project support to a variety of different customers, from innovative biotech to global giant pharmaceutical companies.

Bellen is committed to continue investing in innovation and state-of-the-art facilities to enable an one-stop-shop chemistry service platform, adding value to your project from library synthesis to API GMP manufactory.